Newpace
Subcutaneous Implantable Cardioverter Defibrillator
Active
Seed
Startup
Caesarea
Founded 2012-10
NewPace develops a flexible and subcutaneous implantable cardioverter defibrillator (ICD) with no leads within the heart with a wireless rechargeable battery and Bluetooth communication. The NewPace defibrillator differs from standard ICDs in that it does not have leads in the heart. The rechargeable device is implanted subcutaneously with no need for fluor…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$2.0M
Employees4
Founded2012-10
HQCaesarea
Patents1
Confidence90
Sectors
Health Tech & Life SciencesMedical DevicesLife Support
Technology
CommunicationsBluetoothMaterials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders